Institutional investors purchased a net $3.0 million shares of OPK during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 18.50% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 1.6 Million shares of OPKO Health Inc
D. E. SHAW & CO. LP Bought 968.1 Thousand shares of OPKO Health Inc
BLACKROCK FUND ADVISORS Bought 824.1 Thousand shares of OPKO Health Inc